Viewing nowTrurina Tablets (Linagliptin)
Linagliptin 5mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

MFDS item code 201900708 · Approved 2019.01.30 · Insurance code 641906980
Improvement of blood sugar control in type 2 diabetes
This medication is an adjunct to diet and exercise for helping patients with type 2 diabetes control their blood sugar levels. It can be used alone or in combination with other medications. This helps effectively improve blood sugar levels and aids in the management of diabetes.
The recommended dosage of this medication is 5 mg once daily. It can be taken regardless of meals.
This medication should not be used by patients who are allergic to the active ingredient or any other components. It should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. When used in combination with insulin or sulfonylureas, which can cause hypoglycemia, caution is required as the risk of hypoglycemia may increase. Experience with this medication in patients with heart failure is limited, and it should be used cautiously. Acute pancreatitis symptoms may occur; therefore, if persistent severe abdominal pain occurs, discontinue use immediately and consult with a physician. A skin condition known as bullous pemphigoid may appear, and if blisters or skin irritation occur, discontinue use immediately and consult with an expert. Symptoms of hypoglycemia may appear while taking this medication, so blood sugar levels should be monitored closely, and appropriate action should be taken if symptoms arise. This medication is not recommended for use during pregnancy or breastfeeding, and nursing mothers should exercise caution when taking it. Safety and efficacy have not been sufficiently demonstrated in children under 10 years old and patients aged 10-17 years, hence it is not recommended. Elderly patients can use this medication without special dosage adjustments, but their condition should be monitored closely. Patients with impaired kidney or liver function can use it without dosage adjustments, but they should follow physician's instructions. Since there is no specific antidote for overdose, symptoms should be monitored and necessary treatment should be provided. This medication should be stored out of reach of children and should not be transferred to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is advisable to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. This way, the effectiveness of the medication can be preserved for a longer time.
Round film-coated tablets of pale pink color
28 tablets - 14 tablets/PTP[X2], 30 tablets - 10 tablets/PTP[X3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLinagliptin 5mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Aju Pharmaceuticals Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Albozen Korea Co., Ltd.
Linagliptin 5mg
Tablet · Prescription medication
Anguk Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Linagliptin 5mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.